Page last updated: 2024-10-18

kynurenine and Spinocerebellar Ataxias

kynurenine has been researched along with Spinocerebellar Ataxias in 1 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Spinocerebellar Ataxias: A group of predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ward, JM1
Stoyas, CA1
Switonski, PM1
Ichou, F1
Fan, W1
Collins, B1
Wall, CE1
Adanyeguh, I1
Niu, C1
Sopher, BL1
Kinoshita, C1
Morrison, RS1
Durr, A1
Muotri, AR1
Evans, RM1
Mochel, F1
La Spada, AR1

Other Studies

1 other study available for kynurenine and Spinocerebellar Ataxias

ArticleYear
Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease.
    Cell reports, 2019, 01-29, Volume: 26, Issue:5

    Topics: Adipose Tissue; Animals; Ataxin-7; Blood Glucose; Energy Metabolism; Humans; Kynurenine; Metabolomic

2019